Corsano #health is launching the company's first-generation wearable device that accurately measures five vital parameters and makes raw PPG and ACC data available for further analysis by third party medical algorithm developers
MEDICA 2021
THE HAGUE, THE NETHERLANDS, November 8, 2021 -- Today, #corsano #health, a leading MedTech company developing, producing, and marketing medical grade continuous #health monitoring announced the launch of its CardioWatch 287 at MEDICA 2021.
MEDICA is the world's largest medical marketplace annually organised in Düsseldorf, taking place this year from 15 – 18 November.
Corsano's CardioWatch 287 accuracy of a state-of-the-art bracelet has been validated in six third party clinical investigations. "The independent validations of #corsano Health's CardioWatch 287 are important evidence to prove accurate measurement of five vital parameters. Moreover, #corsano offers access to raw PPG and ACC data for further analysis to academic researchers and contract research organizations. Corsano's non-invasive ergonomic wearables deliver medically validated data with superior patient compliance." said Drs. Peter Stas, CEO of #corsano #health. "Additionally, patient satisfaction surveys conducted at the closure of the studies cite convenience and ease to use of the CardioWatch 287 devices."
Due to their non-intrusive and convenient nature, wearable devices like Corsano's CardioWatch 287 have great potential for high volume accessible long-term monitoring of at-risk patients.
About #corsano Health
Corsano #health, based in The Netherlands with offices in Switzerland, is a leading wearable MedTech company developing, producing and marketing medical smart monitoring devices designed to measure vital parameters 24/7 using wireless, non-invasive, and medical-grade technology. The Corsanobrand name is derived from in corpore sano (in a healthy body). Corsano's CardioWatch 287 is a cardiac arrhythmia screening system that provides a simple and effective method for continuous monitoring of up to 19 vital parameter measurements (i.e., Heart Rate, RR Intervals, Respiration Rate, SpO2, Sleep, Activity, ECG, BIOZ, Core Body Temperature, Cuffless Blood Pressure).
More information at http://www.corsano.com
4ea07898-3e58-d46e-2a96-a88b7e843884
1080x1080, 202KB
Bracelet B BGLess
1386x1600, 1MB
d85e671e-2308-d98c-27c1-aae7dce16b72
1080x810, 137KB
e2a149fd-c526-bb3c-44cc-7081c0929330
1620x1620, 869KB
Corsano-287-1-Leaflet-2
3MB
Corsano-287-1-Leaflet
3MB
Press release
14KB
Related news |
||
|
|
|
march 26, 2024
|
february 22, 2024
|
december 07, 2021
|
|
Corsano Health is announcing that its CardioWatch 287-2 System received FDA Clearance.The Hague, March 22, 2024 – Corsano Health, ... |
Collaborating researchers from Radboud University Medical Center, Erasmus MC, Reinier de Graaf Hospital, and Corsano Health have s... |
Dutch Heart Foundation awards RadboudMC and #corsano #health a development project to recognize cardiac arrest and alert emergency... |
You might be interested in |
|
august 27, 2021
|
|
Wearable devices accurately measure Heart Rate and RR Intervals in 180 cardiovascular at-risk patientsBUSSUM, THE NETHERLANDS, Aug... |
© Copyright 2024
Download all 
Italian 
Download all 
Share
Share via mail 
Automotive
Sport
Events
Art&Culture
Design
Fashion&Beauty
Food&Hospitality
Technology
Nautica
Racing
Excellence
Corporate
OffBeat
Green
Gift
Pop
Heritage
Entertainment
Health & Wellness